ArticleOncoTargets and therapy2015

-148 C/T polymorphism of Axin2 contributes to a decreased risk of cancer: evidence from a meta-analysis.

AnYuan Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.